BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Ridge Diagnostics, Inc. Wins Growth-Promoting Loan From Biotech Center, Award Will Support NC Laboratory in Commercialization of First Blood Test for Depression


7/10/2009 8:35:25 AM

RESEARCH TRIANGLE PARK, N.C., July 10 /PRNewswire/ -- Ridge Diagnostics, Inc., a neurodiagnostic company with a first-in-class, proprietary blood test for Major Depressive Disorder (MDD), announced the award of a $202,500 loan from the North Carolina Biotechnology Center. The funds will further develop the company's CLIA certified laboratory in Research Triangle Park, thereby supporting the commercialization of its proprietary blood test for depression.

The award was made under the Biotechnology Center's Strategic Growth Loan (SGL) program, which helps promising North Carolina companies succeed in the challenging startup process.

"Ridge Diagnostics is a great example of why the loans from the North Carolina Biotechnology Center are so important," said John Richert, vice president for business and technology development at the North Carolina Biotechnology Center. "By helping them advance their technologies, we enable a strong company to grow stronger, bringing economic opportunity and the prospect of new jobs to the state."

This is the second SGL awarded to Ridge. The company is preparing to launch its multi-analyte blood test for diagnosing clinical depression and monitoring its therapy. The MDDScore(TM) provides objective, biological information associated with physiological changes caused by the condition. The test will be used by physicians to augment traditional diagnostic tools such as behavioral questionnaires and clinical assessments.

"Ridge Diagnostics, once again, would like to thank the NC Biotechnology Center for their ongoing support of the company," said Stan Sewitch, CEO. "By preparing our laboratory for commercial expansion, this Strategic Growth Loan allows us to offer our Clinical Experience Program to physicians and patients in North Carolina and other select areas of the United States."

The Ridge Clinical Experience Program, slated to begin in September, will enable practicing physicians to experience the benefits of the test as an aid in the diagnosis and management of patients with depression.

Ridge Diagnostics, Inc. is a neurodiagnostic company commercializing a breakthrough first-in-class, proprietary blood test for the diagnosis and treatment monitoring of Major Depressive Disorder (MDD). The company's products are based on a proprietary Human Biomarker Library and Hyper-Mapping(TM) analytical technology. Ridge intends to develop a comprehensive program of neuropsychiatric disease diagnostics. Ridge Diagnostics' tests are provided through its CLIA certified laboratory in North Carolina, with plans for diagnostic test kits sold worldwide. The company's research and clinical laboratories are headquartered in Research Triangle Park, NC, with administrative offices in San Diego, CA. www.RidgeDx.com

About the North Carolina Biotechnology Center

The Biotechnology Center, headquartered in Research Triangle Park, is a private, non-profit corporation supported by the NC General Assembly. Its mission is to provide long-term economic and societal benefits to North Carolina by supporting biotechnology research, business, education and strategic policy statewide.

CONTACT: Lonna J. Williams, COO of Ridge Diagnostics, Inc., 1-877-743-4301

Web site: http://www.ridgedx.com/


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->